The Journal of Urology
Volume 176, Issue 2 , Pages 564-568, August 2006

Long-Term Outcome Following Radical Prostatectomy in Men With Clinical Stage T3 Prostate Cancer

  • Brett S. Carver

      Affiliations

    • Corresponding Author InformationCorrespondence: Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, 353 East 68th St., New York, New York 10021 (telephone: 212-639-8266; FAX: 212-988-0759).
    • ,
  • Fernando J. Bianco Jr.
    • ,
  • Peter T. Scardino

      Affiliations

    • Financial interest and/or other relationship with Steba Pharmaceuticals, Oncovance Inc., Merck, Sanofi Aventis, National Cancer Institute, National Institutes of Health, Prostate Cancer Foundation, AstraZeneca, Penguin Putnam Inc. and Nature Urology.
    • ,
  • James A. Eastham

      Affiliations

    • Financial interest and/or other relationship with Novartis.

Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York

Received 15 August 2005

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 See Editorial on page 437.

PII: S0022-5347(06)00781-6

doi:10.1016/j.juro.2006.03.093

Refers to article:

  • Radical Prostatectomy—Which Patients Benefit Most From Surgery?

    Joseph A. Smith
    The Journal of Urology August 2006 (Vol. 176, Issue 2, Page 437)

The Journal of Urology
Volume 176, Issue 2 , Pages 564-568, August 2006

Article Tools

* Image Usage & Resolution